Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Inhibiting ataxia telangiectasia and Rad3-related protein (ATR)

Inhibiting ataxia telangiectasia and Rad3-related protein (ATR)

US Patent 10570119 · Granted Feb 25, 2020

Estimated economic value: $508,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Carotenoid compositions and uses thereof2025
Closed-ended DNA vectors obtainable from cell-free synthesis and process for obt2025
Viral inhibitors, the synthesis thereof, and intermediates thereto2025
Lipid nanoparticles for delivery of nucleic acids and methods of use thereof2025
Lipid nanoparticles for delivery of nucleic acids and methods of use thereof2025
Lipid nanoparticles for delivery of nucleic acids and methods of use thereof2025
Viral inhibitors, the synthesis thereof, and intermediates thereto2025
Viral inhibitors, the synthesis thereof, and intermediates thereto2025
Neutrophil exocytosis inhibitors2025
Oxazolidinone compounds, liposome compositions comprising oxazolidinone compound2024
Oxazolidinone compounds, liposome compositions comprising oxazolidinone compound2024
Oxazolidinone compounds, liposome compositions comprising oxazolidinone compound2024